Change language dansk English suomi svenska

Generate Estimates Confirm Cancel Hide empty rows Show hidden rows DummyText

MEDI-FLOWERY ApS Estimate generation in progress, please wait... 0%

Quicksearch from your own companies XBRLDenmark Analyst: XBRLDenmark

Loading... Loading... Loading... Loading...   Loading...

1000.0 Bankruptcy Risk  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Bankruptcy risk for industry   1.5% 1.5% 1.5% 1.5% 1.5% 1.5% 2.1% 2.1%   Bankruptcy risk   1.3% 1.3% 1.4% 2.2% 2.4% 2.5% 10.0% 10.0%   Credit score (0-100)   81 81 79 64 63 61 25 25   Credit rating   A A A BBB BBB BBB BB BB   Credit limit (kDKK)   25.6 34.7 29.1 0.1 0.0 0.0 0.0 0.0   How are these values calculated?   View the automatically generated explanation of bankruptcy risk 1000.0 Income statement (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Gross profit   380 286 268 153 130 160 0.0 0.0   EBITDA   181 72.3 -7.5 -104 -140 -202 0.0 0.0   EBIT   181 72.3 -7.5 -104 -140 -202 0.0 0.0   Pre-tax profit (PTP)   637.1 703.0 953.0 94.1 -663.9 37.5 0.0 0.0   Net earnings   598.5 677.4 851.4 94.1 -687.4 37.5 0.0 0.0   Pre-tax profit without non-rec. items   637 703 953 94.1 -664 37.5 0.0 0.0     See the entire income statement 1000.0 Balance sheet (kDKK)  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Tangible assets total   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Shareholders equity total   2,011 2,688 2,990 3,028 2,283 2,335 958 958   Interest-bearing liabilities   274 293 334 317 317 333 0.0 0.0   Balance sheet total (assets)   2,348 3,079 3,425 3,407 2,669 2,745 958 958   Net Debt   -385 133 -80.8 212 -318 -262 -958 -958     See the entire balance sheet 1000.0 Volume  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales   0 0 0 0 0 0 0 0   Net sales growth   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Gross profit   380 286 268 153 130 160 0.0 0.0   Gross profit growth   0.0% -24.6% -6.5% -42.7% -15.3% 22.8% -100.0% 0.0%   Employees   0 0 0 0 0 0 0 0   Employee growth %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Employee expenses   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Balance sheet total (assets)   2,348 3,079 3,425 3,407 2,669 2,745 958 958   Balance sheet change%   32.1% 31.1% 11.2% -0.5% -21.7% 2.9% -65.1% 0.0%   Added value   181.5 72.3 -7.5 -103.8 -140.2 -201.9 0.0 0.0   Added value %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Investments   0 0 0 0 0 0 0 0   Net sales trend   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   EBIT trend   1.0 2.0 -1.0 -2.0 -3.0 -4.0 0.0 0.0   1000.0 Profitability  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A EBITDA %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   EBIT to gross profit (%)   47.7% 25.2% -2.8% -67.6% -107.8% -126.4% 0.0% 0.0%   Net Earnings %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Profit before depreciation and extraordinary items %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Pre tax profit less extraordinaries %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   ROA %   31.2% 26.8% 29.5% 3.9% -1.5% 2.1% 0.0% 0.0%   ROI %   32.0% 27.6% 30.4% 3.9% -1.6% 2.2% 0.0% 0.0%   ROE %   35.0% 28.8% 30.0% 3.1% -25.9% 1.6% 0.0% 0.0%   1000.0 Solidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Equity ratio %   85.6% 87.3% 87.3% 88.9% 85.5% 85.1% 100.0% 100.0%   Relative indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Relative net indebtedness %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net int. bear. debt to EBITDA, %   -212.0% 183.5% 1,082.9% -204.3% 226.7% 130.0% 0.0% 0.0%   Gearing %   13.6% 10.9% 11.2% 10.5% 13.9% 14.3% 0.0% 0.0%   Net interest   0 0 0 0 0 0 0 0   Financing costs %   2.1% 8.3% 2.1% 11.5% 194.9% 6.1% 0.0% 0.0%   1000.0 Liquidity  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Quick Ratio   3.0 2.9 4.0 4.8 4.6 3.8 0.0 0.0   Current Ratio   3.2 2.9 4.0 4.8 4.6 3.8 0.0 0.0   Cash and cash equivalent   659.0 160.7 414.6 104.8 634.6 595.4 0.0 0.0   1000.0 Capital use efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Trade debtors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Trade creditors turnover (days)   0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0   Current assets / Net sales %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   Net working capital   748.1 757.2 1,306.0 1,457.0 1,378.6 1,143.7 0.0 0.0   Net working capital %   0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0% 0.0%   1000.0 Employee efficiency  2018 2018/12 2019 2019/12 2020 2020/12 2021 2021/12 2022 2022/12 2023 2023/12 2024e N/A 2025e N/A Net sales / employee   0 0 0 0 0 0 0 0   Added value / employee   0 0 0 0 0 0 0 0   Employee expenses / employee   0 0 0 0 0 0 0 0   EBITDA / employee   0 0 0 0 0 0 0 0   EBIT / employee   0 0 0 0 0 0 0 0   Net earnings / employee   0 0 0 0 0 0 0 0